John Lewicki
Vermögen: 31 932 $ am 31.05.2026
Vermögen: 31 932 $ am 31.05.2026
Dr. John A. Lewicki is a Chief Scientific Officer at Mereo BioPharma Group Plc.
Dr. Lewicki was previously employed as a President, Chief Executive Officer & Director by OncoMed Pharmaceuticals, Inc. and a Principal by Scios, Inc. He received his doctorate degree from the University of California San Diego.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2026 | 464 130 ( 0,06 % ) | 31 932 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Vorstandsvorsitzender | 23.04.2019 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen